The latest biotech news

News and Trends 8 Jan 2018

Biotech in London Paves the Way for a New Therapy for Ulcerative Colitis

TopiVert has successfully completed a Phase I trial in ulcerative colitis with a new class of drug that could help reduce adverse side effects. The results of a Phase I trial run by London-based biotech TopiVert have shown potential for a new type of therapy for ulcerative colitis. The study revealed that the drug, called […]

January 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Jan 2018

This British Liquid Biopsy Could Save Us $5000 per Prostate Cancer Patient

ANGLE’s liquid biopsy technology measures the expression of an important prostate cancer biomarker, helping to identify the best treatment for different groups of patients. ANGLE is a world leader in the development of liquid biopsies – a technique for the early detection of cancer, which doesn’t require invasive tissue samples. The biotech published results in […]

January 8, 2018 - 3 minutesmins - By Alex Dale

News and Trends 8 Jan 2018

This Skin Patch Could Slow the Rate of Antibiotic Resistance

Researchers have developed a skin patch that delivers drugs directly into the blood, avoiding the gut which is a breeding ground for antibiotic resistance. Researchers at Queen’s University Belfast are developing a skin patch to deliver drugs through the skin and directly into the bloodstream via thousands of ‘microneedles’. The technology is being tested as a […]

January 8, 2018 - 3 minutesmins - By Alex Dale

takeda tigenix acquisition stem cell therapy

News and Trends 5 Jan 2018

Takeda Starts the Year Bidding for a Belgian Stem Cell Therapy Biotech

Takeda has offered to acquire TiGenix subject to the upcoming European approval of its lead stem cell therapy for Crohn’s disease, Cx601. Short of two years after partnering with TiGenix for the development of a stem cell therapy, Takeda has offered to buy the remaining shares of the company in Euronext Brussels and the Nasdaq […]

January 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Jan 2018

Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech

Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of its venture fund to €250M, which will allow it to expand its focus. Boehringer Ingelheim is a big pharma hoping to drive the development of new and effective medicines. Today, the company announced that it has more than doubled the size of […]

January 4, 2018 - 2 minutesmins - By Alex Dale

News and Trends 4 Jan 2018

German Biotech Raises Record $270M Series A for Individualized Cancer Therapies

BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and mRNA technologies. BioNTech is kicking off the new year with great news. The company has closed its Series A with $270M (€225M) — a record amount in Germany for such an early funding round. The fundraising was led by the […]

January 4, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Jan 2018

Enterome Brings in a €32M Series D for its Microbiome-Based Therapies

Enterome will use the money to progress two of its leading microbiome programs for the treatment of Crohn’s disease and an aggressive form of brain cancer. Enterome is a pioneer in the exciting field of microbiome-based therapies for diseases like inflammatory bowel diseases and cancer. This morning, the company has announced that it has raised €32M in […]

January 4, 2018 - 3 minutesmins - By Alex Dale

News and Trends 4 Jan 2018

Swedish Biotech Pockets $6M as its Cancer Antibody Heads for the Clinic

Alligator Bioscience will receive milestone payments from its partner, Janssen, following the announcement of a combination trial using its cancer antibody. Alligator develops antibodies to fight cancer, and today it has announced that it will receive $6M (€5M) in milestone payments from Janssen. This was triggered by the announcement of a combination trial for its candidate, ADC-1013, which […]

January 4, 2018 - 2 minutesmins - By Alex Dale

News and Trends 3 Jan 2018

Swiss Biotech Gets $339M to Boost the Development of Drug Addiction Therapies

Addex Therapeutics, which develops drugs for neurological disorders, has signed an agreement with Indivior to propel its drug addiction pipeline forward. Addex, a top biotech from Geneva, develops small molecules for the treatment of neurological disorders. Today, the company has announced that a collaboration worth up to $339M (€282M) has been signed with Indivior that will focus on progressing […]

January 3, 2018 - 3 minutesmins - By Alex Dale

News and Trends 3 Jan 2018

What Are Clinical Trials and Why Do We Do Them?

If you’ve read any of our articles, you’ll have no doubt heard us banging on about clinical trials, Phase I, Phase II, market approval… But what does this all mean? We’ve put together a quick guide to help you through these crucial stages of drug development. To reach a clinical trial, the drug will have […]

January 3, 2018 - 6 minutesmins - By Alex Dale

News and Trends 23 Dec 2017

Biota Beats: Music from the Microbiome

Bacteria and music are two completely unrelated concepts for most of us. But not for the group of artists and scientists behind Biota Beats. The iGEM synthetic biology competition gathers teams of enthusiastic students every year in Boston. But this year, it also gathered the bacteria of the participants. The team from Biota Beats asked […]

December 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Dec 2017

Scientists Find New Immune Target to Stop Progression of Alzheimer’s

Scientists have described a new mechanism by which the immune system can drive Alzheimer’s and shown that blocking it can prevent the disease in mice. A study published yesterday in Nature details how a molecule involved in the innate immune response can promote the aggregation of amyloid-β plaques that appear in the brains of patients […]

December 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Biotech in London Paves the Way for a New Therapy for Ulcerative Colitis

This British Liquid Biopsy Could Save Us $5000 per Prostate Cancer Patient

This Skin Patch Could Slow the Rate of Antibiotic Resistance

Takeda Starts the Year Bidding for a Belgian Stem Cell Therapy Biotech

Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech

German Biotech Raises Record $270M Series A for Individualized Cancer Therapies

Enterome Brings in a €32M Series D for its Microbiome-Based Therapies

Swedish Biotech Pockets $6M as its Cancer Antibody Heads for the Clinic

Swiss Biotech Gets $339M to Boost the Development of Drug Addiction Therapies

What Are Clinical Trials and Why Do We Do Them?

Biota Beats: Music from the Microbiome

Scientists Find New Immune Target to Stop Progression of Alzheimer’s

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!